Cd69 and sbk1 as potential predictors of responses to pd-1/pd-l1 blockade cancer immunotherapy in lung cancer and melanoma

HIGHLIGHTS

• who: Zhang-Wei Hu from the United States Yat-sen University Cancer Center have published the research: CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma, in the Journal: (JOURNAL)
• what: CD69 has a double-edged effect in tumor immunity and here, the authors show that it may effectively predict response to PD-1/PDL1 blockade. This analysis showed that CD69 is aberrantly expressed in most TCGA tumors, and that its expression positively correlated with most immune checkpoints and immune cell infiltration of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.